logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Government backs down over E-Bacs

7 February 2013

The government has scrapped its controversial plans to phase out GCSEs in core subjects and replace them with a new qualification, the English Baccalaureate Certificate.

The policy has been heavily criticised by teaching unions, the exam regulator and, most recently, by a committee of MPs. Plans to replace the system of multiple exam boards with a single administrator for each subject have also been shelved, with ministers fearing the proposals would fall foul of EU procurement laws.

While many will accuse Michael Gove of performing an embarrassing U-turn, the truth is that the government is still planning to press ahead with key elements of its original plan, including scrapping coursework and introducing new league tables (measuring value added across a range of 8 GCSEs). The government has taken a bold decision to rethink its flagship policy; perhaps it should not be castigated for listening to the concerns of stakeholders.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up